Shot
Another round of massive layoffs likely at NDTV, nearly 100 get notices
Adani-owned NDTV appears to be heading toward another round of layoffs, with employees across departments being put on performance improvement programmes.
While the exact number remains unclear, several staffers estimate that close to 100 employees may be affected this time. Those who have received PIP notices include reporters, anchors, camera crew, desk staff from both Hindi and English channels, PCR personnel, and even some team heads.
An email from HR has asked them to see the PIP as a “preliminary warning” for their performance that is “not meeting expectations”. It added that if performance does not improve, “continued employment may be reconsidered”. All the PIP deadlines conclude in March.
“Being put on PIP here essentially means you’re going to lose your job,” said a senior employee. Last April, ahead of appraisals, around 100 employees were similarly placed on PIPs. Most of them subsequently exited the organisation.
After the Adani Group acquired control of NDTV in December 2022, the newsroom saw a wave of high-profile exits. Since then, rounds of resignations and layoffs have continued intermittently.
In April 2025, employees had told Newslaundry that staff associated with the “old NDTV” – shorthand for the Prannoy Roy era – were disproportionately affected.
Newslaundry has emailed NDTV’s HR department with detailed queries regarding the reported PIPs and possible layoffs. A response is awaited.
Small teams can do great things. All it takes is a subscription. Subscribe now and power Newslaundry’s work.
Also Read
-
Explained: What the Union government’s new delimitation bills change and why it matters
-
‘Bid to move us to Bangladesh’: At the Bengal poll booths where every second voter is gone
-
‘At least tell us you have him’: Families search for ‘missing’ workers after Noida crackdown
-
Jobs, corruption, SIR | Mahua Moitra on the Mamata mandate
-
Dead children, dirty drugs, a giant ‘racket’: The curious case of Digital Vision Pharma